Highlights and Quick Summary
- Non-operating Income/Expense for the quarter ending June 30, 2022 was $-210 Thousand (a -99.36% decrease compared to previous quarter)
- Year-over-year quarterly Non-operating Income/Expense decreased by -77.75%
- Annual Non-operating Income/Expense for 2021 was $84 Million (a 13.44% increase from previous year)
- Annual Non-operating Income/Expense for 2021 was $74.1 Million (a -1374.5% decrease from previous year)
- Annual Non-operating Income/Expense for 2020 was $-5.81 Million (a 1143.43% increase from previous year)
- Twelve month Non-operating Income/Expense ending June 30, 2022 was $31.4 Million (a -0.93% decrease compared to previous quarter)
- Twelve month trailing Non-operating Income/Expense decreased by -1206.42% year-over-year
Trailing Non-operating Income/Expense for the last four month:
| 30 Jun '22 | 31 Mar '22 | 31 Dec '21 | 30 Sep '21 |
|---|---|---|---|
| $31.4 Million | $31.7 Million | $63.6 Million | $-2.84 Million |
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-operating Income/Expense of Biofrontera AG Sponsored ADR
Most recent Non-operating Income/Expenseof BFAGY including historical data for past 10 years.Interactive Chart of Non-operating Income/Expense of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | $-0.21 | $-32.83 | – |
| 2021 | $65.41 | $-0.95 | $0.09 | $-0.95 | $84.03 |
| 2020 | $-1.03 | $-2.76 | $-1.39 | $1.18 | $-5.81 |
| 2019 | – | $0.11 | $-3.69 | $0.15 | $20.83 |
| 2018 | – | – | – | $-0.51 | $-0.93 |
| 2017 | – | – | $-0.77 | $-0.25 | $-2.45 |
| 2016 | – | – | – | – | $1.33 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic